Bull Harbor Capital LLC Makes New Investment in Globe Life Inc. $GL

Bull Harbor Capital LLC purchased a new stake in Globe Life Inc. (NYSE:GL) during the first quarter, according to the company in its most recent filing with the SEC. The firm purchased 3,865 shares of the company’s stock, valued at approximately $538,000.

Several other institutional investors also recently made changes to their positions in the stock. Vanguard Group Inc. increased its holdings in shares of Globe Life by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock worth $1,411,311,000 after buying an additional 86,349 shares during the last quarter. Invesco Ltd. boosted its holdings in Globe Life by 2.7% in the fourth quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock valued at $552,262,000 after acquiring an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Globe Life by 10.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after acquiring an additional 217,331 shares during the last quarter. Morgan Stanley grew its position in Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after acquiring an additional 125,567 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its position in Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after acquiring an additional 355,399 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

Globe Life Stock Performance

NYSE:GL opened at $182.14 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $14.14 billion, a price-to-earnings ratio of 12.09 and a beta of 0.47. The firm’s fifty day simple moving average is $171.52 and its 200 day simple moving average is $154.26. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business had revenue of $1.60 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the company posted $3.05 earnings per share. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, equities research analysts expect that Globe Life Inc. will post 15.7 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, EVP Michael Clay Majors sold 37,000 shares of the firm’s stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the sale, the executive vice president directly owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 20,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $156.68, for a total value of $3,133,600.00. Following the sale, the chief executive officer owned 54,020 shares in the company, valued at approximately $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 169,174 shares of company stock worth $28,553,849. Company insiders own 2.11% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on GL. Jefferies Financial Group upped their price target on Globe Life from $147.00 to $166.00 and gave the stock a “hold” rating in a research note on Friday, July 10th. TD Cowen lifted their price objective on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their target price on Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a report on Tuesday, July 21st. Keefe, Bruyette & Woods dropped their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a research report on Friday, July 24th. Finally, Truist Financial raised their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Globe Life currently has an average rating of “Moderate Buy” and a consensus price target of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.